Drug Shortage Report for RECOMBIVAX HB
| Report ID | 52350 |
| Drug Identification Number | 02245977 |
| Brand name | RECOMBIVAX HB -(ADULT DIALYSIS-PRESERVATIVE FREE) |
| Common or Proper name | (hepatitis B vaccine [recombinant]) |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 40MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1DOSE VIAL |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-06-18 |
| Actual start date | 2018-06-18 |
| Estimated end date | 2021-04-05 |
| Actual end date | 2021-03-15 |
| Shortage status | Resolved |
| Updated date | 2021-03-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-06-13 | English | Compare |